Basic Information
Immune Design Utilizes Breakthrough Technology to Develop Safe and Effective Vaccines and Therapies, Aiming to Prevent and Treat Infectious Diseases. G100, Immune Design's Lead Product, is Designed to Leverage a Range of Endogenous Antigens (Including Neoantigens) Found in the Tumor Microenvironment to Generate Systemic Anti-Tumor Immune Responses from Local Injections.
Immune Design Corp.
Seattle,Washington,United States of America
15~50 people
January 01, 2008
info@immunedesign.com
Enterprise Profile
Industrial Sector
Technology
Application Scenarios